Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-05 Sale | 2026-10-07 4:02 pm | TriSalus Life Sciences Inc. | TLSI | Cox Bryan F. Chief of Research | 296 | $4.39 | $1,299 | 162,805 (Direct) | View |
| 2026-10-05 Sale | 2026-10-07 4:02 pm | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Chief Commercial Officer | 325 | $4.39 | $1,427 | 127,994 (Direct) | View |
| 2026-10-05 Sale | 2026-10-07 4:02 pm | TriSalus Life Sciences Inc. | TLSI | Stevens Jennifer Chief Regulatory Officer | 316 | $4.39 | $1,387 | 123,794 (Direct) | View |
| 2026-05-15 Sale | 2026-05-19 4:08 pm | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Chief Commercial Officer | 543 | $2.67 | $1,450 | 125,101 (Direct) | View |
| 2026-05-15 Purchase | 2026-05-18 4:42 pm | TriSalus Life Sciences Inc. | TLSI | Wahlstrom Mats Director | 60,000 | $2.53 | $151,800 | 2,962,030 (Indirect Direct) | View |
| 2026-05-15 Purchase | 2026-05-18 4:42 pm | TriSalus Life Sciences Inc. | TLSI | Stansky Michael P Director | 610,000 | $2.5 | $1,525,000 | 1,640,420 (Indirect Direct) | View |
| 2026-05-15 Purchase | 2026-05-18 4:42 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 39,682 | $2.59 | $102,776 | 1,065,215 (Direct) | View |
| 2026-05-15 Purchase | 2026-05-18 4:42 pm | TriSalus Life Sciences Inc. | TLSI | Patience David Chief Financial Officer | 7,100 | $2.43 | $17,253 | 275,757 (Direct) | View |
| 2026-05-15 Purchase | 2026-05-18 4:42 pm | TriSalus Life Sciences Inc. | TLSI | Gordon Gary B. Director | 10,000 | $2.46 | $24,600 | 72,510 (Direct) | View |
| 2026-03-11 Sale | 2026-03-20 4:25 pm | TriSalus Life Sciences Inc. | TLSI | Devlin Jodi Chief of Clinical Operations | 3,207 | $4.107 | $13,171 | 97,364 (Direct) | View |
| 2026-03-11 Sale | 2026-03-20 4:25 pm | TriSalus Life Sciences Inc. | TLSI | Cox Bryan F. Chief of Research | 3,184 | $4.1098 | $13,085 | 163,415 (Direct) | View |
| 2026-03-11 Sale | 2026-03-20 4:25 pm | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Chief Commercial Officer | 3,457 | $4.1104 | $14,210 | 110,397 (Direct) | View |
| 2026-03-11 Sale | 2026-03-20 4:25 pm | TriSalus Life Sciences Inc. | TLSI | Stevens Jennifer Chief Regulatory Officer | 3,530 | $4.1102 | $14,509 | 124,110 (Direct) | View |
| 2026-03-11 Sale | 2026-03-20 4:25 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 20,302 | $3.9101 | $79,383 | 752,987 (Direct) | View |
| 2026-02-23 Purchase | 2026-02-23 4:08 pm | TriSalus Life Sciences Inc. | TLSI | Patience David Chief Financial Officer | 3,657 | $4.1 | $14,994 | 268,657 (Direct) | View |
| 2026-02-23 Purchase | 2026-02-23 4:08 pm | TriSalus Life Sciences Inc. | TLSI | Gordon Gary B. Director | 9,756 | $4.1 | $40,000 | 9,756 (Direct) | View |
| 2026-02-23 Purchase | 2026-02-23 4:08 pm | TriSalus Life Sciences Inc. | TLSI | Valle William Director | 30,487 | $4.1 | $124,997 | 30,487 (Direct) | View |
| 2026-02-23 Purchase | 2026-02-23 4:08 pm | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 30,487 | $4.1 | $124,997 | 773,289 (Direct) | View |
| 2026-02-23 Purchase | 2026-02-23 4:08 pm | TriSalus Life Sciences Inc. | TLSI | Stansky Michael P Director | 361,098 | $4.1 | $1,480,502 | 986,830 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-10-05 Tax Withholding | 2026-10-07 4:02 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 2,693 | $4.38 | 1,074,990 (Direct) | View |
| 2026-07-01 Tax Withholding | 2026-07-06 4:01 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Patience David Chief Financial Officer | 14,650 | $4.46 | 261,107 (Direct) | View |
| 2026-06-30 Option Award | 2026-07-01 4:04 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 3,990 | $3.87 | 1,077,683 (Direct) | View |
| 2024-12-31 Ownership | 2026-07-01 4:03 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 3,530 | $4.26 | 1,023,826 (Direct) | View |
| 2025-12-31 Ownership | 2026-07-01 4:03 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 2,100 | $4.38 | 1,023,826 (Direct) | View |
| 2025-06-30 Ownership | 2026-07-01 4:03 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 2,848 | $4.23 | 1,023,826 (Direct) | View |
| 2026-06-30 Option Award | 2026-07-01 4:02 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Chief Commercial Officer | 561 | $3.87 | 128,319 (Direct) | View |
| 2024-12-31 Ownership | 2026-07-01 4:01 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Chief Commercial Officer | 999 | $4.26 | 131,758 (Direct) | View |
| 2025-12-31 Ownership | 2026-07-01 4:01 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Chief Commercial Officer | 449 | $4.38 | 131,758 (Direct) | View |
| 2025-06-30 Ownership | 2026-07-01 4:01 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Chief Commercial Officer | 930 | $4.23 | 131,758 (Direct) | View |
| 2024-06-30 Ownership | 2026-07-01 4:01 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Marshak Richard Chief Commercial Officer | 279 | $4.69 | 131,758 (Direct) | View |
| 2026-06-29 Option Award | 2026-06-29 4:33 pm | N/A 2036-06-29 | TriSalus Life Sciences Inc. | TLSI | Marshall Richard Henry Chief Medical Officer | 180,000 | $0 | 343,000 (Direct) | View |
Ownership | 2026-06-29 4:30 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Marshall Richard Henry Chief Medical Officer | 0 | $0 | 163,000 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-15 4:39 pm | N/A 2036-05-13 | TriSalus Life Sciences Inc. | TLSI | HICKS KERRY R Director | 84,604 | $0 | 2,463,025 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-15 4:39 pm | N/A 2036-05-13 | TriSalus Life Sciences Inc. | TLSI | Wahlstrom Mats Director | 147,032 | $0 | 3,178,179 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-15 4:39 pm | N/A 2036-05-13 | TriSalus Life Sciences Inc. | TLSI | Gordon Gary B. Director | 109,157 | $0 | 175,163 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-15 4:39 pm | N/A 2036-05-13 | TriSalus Life Sciences Inc. | TLSI | MATLIN DAVID J Director | 107,669 | $0 | 1,444,613 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-15 4:39 pm | N/A 2036-05-13 | TriSalus Life Sciences Inc. | TLSI | Valle William Director | 109,157 | $0 | 195,894 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-15 4:39 pm | N/A 2036-05-13 | TriSalus Life Sciences Inc. | TLSI | Stansky Michael P Director | 90,593 | $0 | 1,169,960 (Direct) | View |
| 2025-07-31 Conversion | 2026-04-20 4:36 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Frankenius Equity AB 10% Owner | 989,000 | $0 | 6,989,748 (Direct) | View |
| 2025-07-31 Conversion | 2026-04-01 4:09 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | MATLIN DAVID J Director | 430,000 | $0 | 1,271,944 (Direct) | View |
| 2026-02-04 Option Award | 2026-02-11 6:51 pm | N/A 2036-02-03 | TriSalus Life Sciences Inc. | TLSI | Stansky Michael P Director | 92,537 | $0 | 92,537 (Direct) | View |
Ownership | 2026-02-11 6:50 pm | N/A N/A | TriSalus Life Sciences Inc. | TLSI | Stansky Michael P Director | 0 | $0 | 1,453,232 (Direct) | View |
| 2025-11-24 Option Award | 2025-11-25 4:15 pm | N/A 2035-11-23 | TriSalus Life Sciences Inc. | TLSI | Cox Bryan F. Chief of Research | 120,000 | $0 | 428,553 (Direct) | View |
| 2025-11-24 Option Award | 2025-11-25 3:56 pm | N/A 2025-11-23 | TriSalus Life Sciences Inc. | TLSI | Devlin Jodi Chief of Clinical Operations | 150,000 | $0 | 564,321 (Direct) | View |
| 2025-11-24 Option Award | 2025-11-25 3:55 pm | N/A 2035-11-23 | TriSalus Life Sciences Inc. | TLSI | Szela Mary T CEO and President | 800,000 | $0 | 2,320,984 (Direct) | View |